105 related articles for article (PubMed ID: 6391100)
21. Effects of manidipine on blood pressure and renal function in salt-loaded, spontaneously hypertensive rats.
Ikenaga H; Suzuki H; Saruta T
Blood Press Suppl; 1992; 3():75-9. PubMed ID: 1343295
[TBL] [Abstract][Full Text] [Related]
22. Role of renal dopamine D1 receptors in natriuresis induced by calcium channel blockers.
Eisner GM; Yamaguchi I; Felder RA; Asico LD; Jose PA
Am J Physiol; 1994 Dec; 267(6 Pt 2):F965-70. PubMed ID: 7810704
[TBL] [Abstract][Full Text] [Related]
23. Comparison of renal responses to ouabain and ethacrynic acid.
Lie M; Sejersted OM; Raeder M; Kiil F
Am J Physiol; 1974 May; 226(5):1121-6. PubMed ID: 4824865
[No Abstract] [Full Text] [Related]
24. Effects of felodipine on natriuresis, atrial natriuretic factor, the renin-angiotensin-aldosterone system, and blood pressure in essential hypertension.
Cerasola G; Cottone S; Mangano MT; D'Ignoto G; Pinto A; Carone MB
Clin Ther; 1988; 10(6):694-703. PubMed ID: 2975530
[TBL] [Abstract][Full Text] [Related]
25. Role of Mas receptor antagonist (A779) on pressure diuresis and natriuresis and renal blood flow in the absence of angiotensin II receptors type 1 and 2 in female and male rats.
Mansoori A; Oryan S; Nematbakhsh M
J Physiol Pharmacol; 2014 Oct; 65(5):633-9. PubMed ID: 25371522
[TBL] [Abstract][Full Text] [Related]
26. Effect of cyclic adenosine monophosphate on renal function and renin secretion.
Gaál K; Forgács I
Acta Physiol Acad Sci Hung; 1975; 46(1):9-18. PubMed ID: 192043
[TBL] [Abstract][Full Text] [Related]
27. Ca2+ channel subtypes and pharmacology in the kidney.
Hayashi K; Wakino S; Sugano N; Ozawa Y; Homma K; Saruta T
Circ Res; 2007 Feb; 100(3):342-53. PubMed ID: 17307972
[TBL] [Abstract][Full Text] [Related]
28. Renal effects of nitrendipine.
Ruilope LM
J Cardiovasc Pharmacol; 1991; 18 Suppl 5():S10-3. PubMed ID: 1725795
[TBL] [Abstract][Full Text] [Related]
29. Acute effects of iloprost on blood pressure, heart rate, renal hemodynamics, diuresis, natriuresis, plasma renin activity and plasma norepinephrine in uninephrectomized hypertensive mongrel dogs.
Villa E; Morales ME; Martinez J; de la Fuente A; Hurtado A; Santirso RA; Ruilope LM; Sancho JM; García-Robles R
J Hypertens Suppl; 1991 Dec; 9(6):S352-3. PubMed ID: 1726369
[No Abstract] [Full Text] [Related]
30. Effects of calcium entry blockers on renin-angiotensin-aldosterone system, renal function and hemodynamics, salt and water excretion and body fluid composition.
Bauer JH; Sunderrajan S; Reams G
Am J Cardiol; 1985 Dec; 56(16):62H-67H. PubMed ID: 2933950
[TBL] [Abstract][Full Text] [Related]
31. Comparative renal effects of calcium channel blockers in conscious spontaneously hypertensive rats.
Vemulapalli S; Chiu PJ; Sybertz EJ
Arch Int Pharmacodyn Ther; 1987 Jun; 287(2):309-22. PubMed ID: 2888444
[TBL] [Abstract][Full Text] [Related]
32. Enalapril and the kidney: renal vasodilation and natriuresis due to the inhibition of angiotensin II formation.
Navis GJ; de Zeeuw D; de Jong PE
J Cardiovasc Pharmacol; 1986; 8 Suppl 1():S30-4. PubMed ID: 2422491
[TBL] [Abstract][Full Text] [Related]
33. A calcium-channel blocker, amlodipine, attenuates insulin antinatriuresis but does not modulate insulin-mediated attenuation of cardiovascular reactivity in healthy man.
Stenvinkel P; Ottosson-Seeberger A; de Potocki K; Alvestrand A
Nephrol Dial Transplant; 1997 Aug; 12(8):1600-7. PubMed ID: 9269636
[TBL] [Abstract][Full Text] [Related]
34. Discussion on the natriuretic effect of calcium antagonists.
Zanchetti A; Leonetti G
J Cardiovasc Pharmacol; 1987; 10 Suppl 1():S161-4. PubMed ID: 2442510
[No Abstract] [Full Text] [Related]
35. Effects of direct renal arterial infusion of bufalin and ouabain in conscious sheep.
Yates NA; McDougall JG
Br J Pharmacol; 1993 Mar; 108(3):627-30. PubMed ID: 8385530
[TBL] [Abstract][Full Text] [Related]
36. Cardiovascular and renal actions of endothelin: effects of calcium-channel blockers.
Cao LQ; Banks RO
Am J Physiol; 1990 Feb; 258(2 Pt 2):F254-8. PubMed ID: 2178443
[TBL] [Abstract][Full Text] [Related]
37. Role of intrarenal angiotensin II in mediating renal response to volume expansion.
Pinilla JM; Perez MC; Hernandez I; Quesada T; García-Estañ J; Salazar FJ
Am J Physiol; 1991 Sep; 261(3 Pt 2):R619-25. PubMed ID: 1832268
[TBL] [Abstract][Full Text] [Related]
38. Do calcium channel blockers protect against renal ischemia?
Puschett JB
Am J Nephrol; 1987; 7 Suppl 1():49-56. PubMed ID: 3327381
[TBL] [Abstract][Full Text] [Related]
39. Effects of the calcium antagonist manidipine on renal hemodynamics and function in dogs: comparison with nifedipine.
He H; Tamaki T; Aki Y; Kiyomoto H; Iwao H; Miyatake A; Abe Y
Blood Press Suppl; 1992; 3():68-74. PubMed ID: 1343294
[TBL] [Abstract][Full Text] [Related]
40. Effect of the novel T-selective calcium channel antagonist mibefradil on kidney function in comparison with amlodipine.
Greven J
Arzneimittelforschung; 1998 Aug; 48(8):806-10. PubMed ID: 9748707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
